Testing effectiveness (Phase 2)Looking for participantsNCT04852328
What this trial is testing
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Washington University School of Medicine 30